Table 3.

Correlation between baseline miRNA plasma levels and diagnostic characteristics in localized/locally advanced PCa patients

		PSA	Needle GS	cT	EAU risk profile	Prostate volume	Age
miRNA‐93	rho:	−0.035	0.048	0.044	0.033	0.020	0.103
	P‐value	0.674	0.570	0.601	0.693	0.814	0.220
miRNA‐21	rho:	0.050	−0.008	0.155	0.112	−0.080	0.212
	P‐value	0.540	0.917	0.060	0.175	0.340	0.010
miRNA‐221	rho:	0.138	0.040	0.118	0.203	0.061	0.196
	P‐value	0.103	0.642	0.165	0.016	0.475	0.020
miRNA‐125b	rho:	0.198	0.171	−0.170	0.230	0.087	0.329
	P‐value	0.043	0.069	0.070	0.015	0.359	0.000

cT, Clinical tumour stage; EAU risk profile, European Association of Urology risk profile; GS, Gleason score; rho‐scores are from Spearman's rank correlation coefficient. Statistically significant values are marked in bold writing.